Published in Proc Natl Acad Sci U S A on March 10, 2011
WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64
Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov (2014) 2.55
Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry. Science (2015) 2.45
Can we safely target the WNT pathway? Nat Rev Drug Discov (2014) 2.31
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin. Proc Natl Acad Sci U S A (2012) 1.98
Drugging Wnt signalling in cancer. EMBO J (2012) 1.63
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.61
Wnt/β-catenin signalling in prostate cancer. Nat Rev Urol (2012) 1.52
RNAi screening: new approaches, understandings, and organisms. Wiley Interdiscip Rev RNA (2011) 1.48
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol (2011) 1.41
Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer (2013) 1.30
A membrane-associated β-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development (2013) 1.26
Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol (2012) 1.11
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. Cancer Discov (2013) 1.10
Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells. Cancer Res (2013) 1.09
Pharmacological modulation of beta-catenin and its applications in cancer therapy. J Cell Mol Med (2013) 1.03
Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proc Natl Acad Sci U S A (2013) 1.01
Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting. Sarcoma (2012) 0.99
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med (2013) 0.96
Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG). ACS Chem Biol (2012) 0.95
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response. J Med Chem (2012) 0.93
The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest (2015) 0.91
E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines. Sci Rep (2014) 0.90
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia. Br J Haematol (2014) 0.90
Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J Gastroenterol (2014) 0.90
Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine. Curr Med Chem (2015) 0.89
Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies. Int J Mol Sci (2014) 0.89
In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis. PLoS One (2013) 0.88
Temporal perturbation of the Wnt signaling pathway in the control of cell reprogramming is modulated by TCF1. Stem Cell Reports (2014) 0.88
Both canonical and non-canonical Wnt signaling independently promote stem cell growth in mammospheres. PLoS One (2014) 0.88
Winning WNT: race to Wnt signaling inhibitors. Proc Natl Acad Sci U S A (2011) 0.87
Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer. Mol Endocrinol (2014) 0.87
LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion. Cell Metab (2015) 0.86
β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J Am Soc Nephrol (2014) 0.86
Inhibitors of endocytosis prevent Wnt/Wingless signalling by reducing the level of basal β-catenin/Armadillo. J Cell Sci (2014) 0.84
PAPTi: a peptide aptamer interference toolkit for perturbation of protein-protein interaction networks. Sci Rep (2013) 0.84
Small molecule modulators of Wnt/β-catenin signaling. Bioorg Med Chem Lett (2013) 0.84
Dishevelled limits Notch signalling through inhibition of CSL. Development (2012) 0.84
Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol (2015) 0.84
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma. Sci Signal (2015) 0.83
Development of anticancer agents targeting the Wnt/β-catenin signaling. Am J Cancer Res (2015) 0.83
Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells. ACS Chem Biol (2014) 0.83
Anti-cancer drug discovery: update and comparisons in yeast, Drosophila, and zebrafish. Curr Mol Pharmacol (2014) 0.82
Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells. Int J Cancer (2014) 0.82
Sequential actions of β-catenin and Bmp pattern the oral nerve net in Nematostella vectensis. Nat Commun (2014) 0.82
Interlocked positive and negative feedback network motifs regulate β-catenin activity in the adherens junction pathway. Mol Biol Cell (2015) 0.80
Inhibition of β-catenin-TCF1 interaction delays differentiation of mouse embryonic stem cells. J Cell Biol (2015) 0.79
Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma. Anticancer Res (2012) 0.79
Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J Cell Commun Signal (2016) 0.79
High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer. Future Oncol (2012) 0.78
Sp5 and Sp8 recruit β-catenin and Tcf1-Lef1 to select enhancers to activate Wnt target gene transcription. Proc Natl Acad Sci U S A (2016) 0.78
Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts. Haematologica (2014) 0.78
Key Fibrogenic Signaling. Curr Pathobiol Rep (2015) 0.78
Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One (2015) 0.77
A Switch in Akt Isoforms Is Required for Notch-Induced Snail1 Expression and Protection from Cell Death. Mol Cell Biol (2015) 0.77
Mechanotransduction activates canonical Wnt/β-catenin signaling to promote lymphatic vascular patterning and the development of lymphatic and lymphovenous valves. Genes Dev (2016) 0.77
β-Catenin Upregulates the Constitutive and Virus-Induced Transcriptional Capacity of the Interferon Beta Promoter through T-Cell Factor Binding Sites. Mol Cell Biol (2015) 0.77
Revisiting the role of Wnt/β-catenin signaling in prostate cancer. Mol Cell Endocrinol (2017) 0.77
Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration. FASEB J (2016) 0.77
Wnt signalling is a bi-directional vulnerability of cancer cells. Oncotarget (2016) 0.76
Novel β-carbolines against colorectal cancer cell growth via inhibition of Wnt/β-catenin signaling. Cell Death Discov (2015) 0.76
Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization. Cell Death Differ (2015) 0.76
β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes. J Neuroinflammation (2016) 0.76
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun (2016) 0.76
Increasing β-catenin/Wnt3A activity levels drive mechanical strain-induced cell cycle progression through mitosis. Elife (2016) 0.75
Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells. Oncotarget (2016) 0.75
Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials. Cancers (Basel) (2016) 0.75
Wnt Signaling and Colorectal Cancer. Curr Colorectal Cancer Rep (2017) 0.75
A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics. EBioMedicine (2016) 0.75
TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3. Sci Rep (2016) 0.75
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest (2016) 0.75
Luciferase reporter assay in Drosophila and mammalian tissue culture cells. Curr Protoc Chem Biol (2014) 0.75
Genetic modifier screens to identify components of a redox-regulated cell adhesion and migration pathway. Methods Enzymol (2013) 0.75
High-Throughput Selectivity Assays for Small-Molecule Inhibitors of β-Catenin/T-Cell Factor Protein-Protein Interactions. ACS Med Chem Lett (2013) 0.75
Actomyosin contractility provokes contact inhibition in E-cadherin-ligated keratinocytes. Sci Rep (2017) 0.75
Microvesicle-mediated Wnt/β-Catenin Signaling Promotes Interspecies Mammary Stem/Progenitor Cell Growth. J Biol Chem (2016) 0.75
Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. PLoS Pathog (2017) 0.75
Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt. PLoS One (2017) 0.75
Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids. Proc Natl Acad Sci U S A (2017) 0.75
Wnt signaling and cancer. Genes Dev (2000) 18.53
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54
WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet (2004) 10.38
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol (2009) 9.43
Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol (1998) 9.24
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature (2009) 9.15
Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta (2003) 7.85
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta (1994) 5.81
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell (2004) 4.98
Functional genomic analysis of the Wnt-wingless signaling pathway. Science (2005) 4.73
CREB-binding protein and p300 in transcriptional regulation. J Biol Chem (2001) 4.67
A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol (2006) 4.55
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol (1994) 4.34
The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell (2001) 4.32
Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene (2006) 4.14
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol (1999) 4.06
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem (2004) 3.73
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science (2003) 3.63
Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene (1999) 3.24
Crystal structure of a beta-catenin/Tcf complex. Cell (2000) 2.93
Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J Cell Biol (1996) 2.89
Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A (1996) 2.75
Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ (1997) 2.74
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. Nat Chem Biol (2010) 2.71
WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev (2000) 2.67
A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell (1986) 2.32
A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway. Nat Genet (2005) 2.26
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene (2005) 2.06
Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol (2006) 1.95
Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry (2005) 1.92
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. EMBO J (2002) 1.91
WNT targets. Repression and activation. Trends Genet (1999) 1.91
Probing immunosuppressant action with a nonnatural immunophilin ligand. Science (1990) 1.88
Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci (2000) 1.81
Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol (2004) 1.68
Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol (2000) 1.67
The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry (2009) 1.58
Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer (2006) 1.53
Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci (2002) 1.50
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene (2002) 1.43
Drosophila alpha-catenin and E-cadherin bind to distinct regions of Drosophila Armadillo. J Biol Chem (1996) 1.36
The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem (2001) 1.35
Dissecting nuclear Wingless signalling: recruitment of the transcriptional co-activator Pygopus by a chain of adaptor proteins. Mech Dev (2005) 1.29
RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1. J Cell Biol (2005) 1.29
Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models. J Am Chem Soc (2007) 1.28
Microregional effects of gemcitabine in HCT-116 xenografts. Cancer Res (2004) 1.24
beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech Dev (1998) 1.24
Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Med Mol Morphol (2007) 1.20
Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J (2001) 1.17
A model system for cell adhesion and signal transduction in Drosophila. Dev Suppl (1993) 1.14
Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis. Liver Int (2005) 1.11
Tcf/Lef transcription factors during T-cell development: unique and overlapping functions. Hematol J (2000) 1.10
Hot spots in Tcf4 for the interaction with beta-catenin. J Biol Chem (2003) 1.07
Beta-catenin: a transforming actor on many stages. Breast Cancer Res (2002) 1.03
Requirement for Pangolin/dTCF in Drosophila Wingless signaling. Proc Natl Acad Sci U S A (2003) 1.01
Identification of Tcf4 residues involved in high-affinity beta-catenin binding. Biochem Biophys Res Commun (1999) 0.96
BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling. Mech Dev (2006) 0.93
Biochemical characterization of the Drosophila axin protein. FEBS Lett (2000) 0.90
Thiazolidinediones downregulate Wnt/beta-catenin signaling via multiple mechanisms in breast cancer cells. J Surg Res (2008) 0.89
Rare activation of the TCF/beta-catenin pathway in ovarian cancer. Gynecol Oncol (2000) 0.89
Ex vivo programmed cell death and the prediction of response to chemotherapy. Curr Treat Options Oncol (2006) 0.85
Links between signal transduction, transcription and adhesion in epithelial bud development. Nature (2003) 4.88
Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev (2004) 4.68
GFP reporters detect the activation of the Drosophila JAK/STAT pathway in vivo. Gene Expr Patterns (2006) 2.96
Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature (2008) 2.46
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet (2013) 2.38
The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement. J Biomed Inform (2010) 2.35
Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res (2003) 2.23
Wnt signaling and breast cancer. Cancer Biol Ther (2004) 2.22
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol (2010) 2.20
Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. Proc Natl Acad Sci U S A (2002) 2.17
Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia (2004) 1.98
Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell (2006) 1.81
Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci U S A (2002) 1.77
Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst (2002) 1.77
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol (2002) 1.75
Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol (2004) 1.68
chinmo is a functional effector of the JAK/STAT pathway that regulates eye development, tumor formation, and stem cell self-renewal in Drosophila. Dev Cell (2010) 1.67
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One (2013) 1.65
Conserved structural elements in the V3 crown of HIV-1 gp120. Nat Struct Mol Biol (2010) 1.63
Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development (2005) 1.62
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.61
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res (2002) 1.59
Maxillofacial fractures at Waikato Hospital, New Zealand: 1989 to 2000. N Z Med J (2005) 1.50
Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Oncogene (2004) 1.47
Wnt signalling regulates myogenic differentiation in the developing avian wing. Development (2003) 1.42
Wnt signaling in liver cancer. Curr Drug Targets (2008) 1.34
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res (2005) 1.32
Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite. Proc Natl Acad Sci U S A (2007) 1.31
Coordinate regulation of neural tube patterning and proliferation by TGFbeta and WNT activity. Dev Biol (2004) 1.28
Is there a role for Notch signalling in human breast cancer? Breast Cancer Res (2003) 1.21
Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop. AIDS Res Hum Retroviruses (2010) 1.21
Tagetitoxin inhibits RNA polymerase through trapping of the trigger loop. J Biol Chem (2011) 1.14
Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA. J Virol (2011) 1.13
miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci (2013) 1.13
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold. Virology (2010) 1.10
Genome-wide expression profiling in the Drosophila eye reveals unexpected repression of notch signaling by the JAK/STAT pathway. Dev Dyn (2009) 1.06
Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure. PLoS One (2011) 1.04
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Mol Ther (2011) 1.03
Could vaccination with AIDSVAX immunogens have resulted in antibody-dependent enhancement of HIV infection in human subjects? Hum Vaccin Immunother (2014) 1.03
Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling. J Biol Chem (2013) 0.94
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol (2006) 0.92
Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. Mol Endocrinol (2005) 0.92
Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Mol Endocrinol (2007) 0.91
DEDUCE Clinical Text: An Ontology-based Module to Support Self-Service Clinical Notes Exploration and Cohort Development. AMIA Jt Summits Transl Sci Proc (2013) 0.90
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir. Biochem Biophys Res Commun (2011) 0.90
Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology (2013) 0.90
Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes. PLoS One (2010) 0.89
Assessment of immunologically relevant dynamic tertiary structural features of the HIV-1 V3 loop crown R2 sequence by ab initio folding. J Vis Exp (2010) 0.88
Structural determinants of PERK inhibitor potency and selectivity. Chem Biol Drug Des (2010) 0.88
Function of the wingless signaling pathway in Drosophila. Methods Mol Biol (2008) 0.87
The JAK/STAT pathway regulates proximo-distal patterning in Drosophila. Dev Dyn (2007) 0.87
Quantitative assessment of masking of neutralization epitopes in HIV-1. Vaccine (2011) 0.85
Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells. Proc Natl Acad Sci U S A (2013) 0.85
LRP6 exerts non-canonical effects on Wnt signaling during neural tube closure. Hum Mol Genet (2013) 0.84
Yan, an ETS-domain transcription factor, negatively modulates the Wingless pathway in the Drosophila eye. EMBO Rep (2011) 0.84
Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies. Adv Virol (2012) 0.84
Distinct sequence patterns characterize the V3 region of HIV type 1 gp120 from subtypes A and C. AIDS Res Hum Retroviruses (2006) 0.82
Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy? Am J Surg (2004) 0.81
Modeling the interaction between aldolase and the thrombospondin-related anonymous protein, a key connection of the malaria parasite invasion machinery. Proteins (2007) 0.81
Wnt-1 expression in PC12 cells induces exon 15 deletion and expression of L-APP. Neurobiol Dis (2004) 0.81
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling. Int J Cardiol (2012) 0.80
Chemosensitivity and resistance assays: a systematic review? J Clin Oncol (2005) 0.80
Mammary stem cells and cancer: roles of Wnt signaling in plain view. Breast Cancer Res (2010) 0.80
Atypical protein kinase Cι is required for Wnt3a-dependent neurite outgrowth and binds to phosphorylated dishevelled 2. J Biol Chem (2013) 0.79
GRB10 binds to LRP6, the Wnt co-receptor and inhibits canonical Wnt signaling pathway. Biochem Biophys Res Commun (2007) 0.79
Activation domains for controlling plant gene expression using designed transcription factors. Plant Biotechnol J (2013) 0.78
Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects. PLoS One (2011) 0.78
Postgenomic technologies targeting the Wnt signaling network. Wiley Interdiscip Rev Syst Biol Med (2011) 0.77
Quantitative analysis of T cell receptor complex interaction sites using genetically encoded photo-cross-linkers. ACS Chem Biol (2014) 0.77
Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate. Protein Eng Des Sel (2010) 0.76
Development of stable isotope and selenomethionine labeling methods for proteins expressed in Pseudomonas fluorescens. Protein Expr Purif (2008) 0.76
Sequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein. AIDS Res Hum Retroviruses (2014) 0.76
HIV's Nef interacts with β-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One (2013) 0.76
Response to letter to the editor. Hum Vaccin Immunother (2015) 0.75
An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. Leuk Lymphoma (2011) 0.75